Takeda Yu, Suzuki Hiroko, Hosono Katsuhiro, Hikoya Akiko, Komori Miwa, Inagaki Risako, Haseoka Takashi, Arai Shinji, Takagi Yuri, Hotta Yoshihiro, Sato Miho
Department of Ophthalmology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu City, Shizuoka, 431-3192, Japan.
Jpn J Ophthalmol. 2022 May;66(3):314-319. doi: 10.1007/s10384-022-00920-5. Epub 2022 Apr 19.
Chronic progressive external ophthalmoplegia (CPEO) is a mitochondrial disease characterized by slowly progressive ptosis and limitations in ocular motility. Although exophthalmos is not considered to be a common feature of CPEO, this study focused on the incidence of exophthalmos in patients with CPEO.
Retrospective observational case series METHODS: We reviewed the clinical charts of patients who received a diagnosis of CPEO sometime during the period between January 2010 and December 2018. CPEO was diagnosed on the basis of detection of a deletion of mitochondrial DNA (mtDNA) from saliva, buccal mucosa, or extraocular muscle specimens obtained during strabismus surgery. Horizontal MRI/CT images or Hertel ophthalmometry was used in determining exophthalmos.
Seven patients (4 males) were identified. The mean age at diagnosis was 32.6 years (range 13-53 years). mtDNA deletion mutations were detected in the buccal mucous membrane DNA in 5 patients and in the saliva and extraocular muscle DNA in 2 patients. MRI/CT was recorded in 6 patients, four of whom showed exophthalmos (cases 1-4), and case 5 was determined as exophthalmos on the basis of a Hertel ophthalmometer reading. Exophthalmos was bilateral in 4 of the patients (cases 1, 2, 4, and 5) and unilateral in 1 patient (case 3). Exophthalmos was the chief concern of 2 of the patients; however, it was not clinically significant in the other patients.
Although exophthalmos may not be recognized by either the patient or the clinician, it may be one of the common features of CPEO. A large multiethnic study should be performed.
慢性进行性眼外肌麻痹(CPEO)是一种线粒体疾病,其特征为上睑下垂逐渐加重以及眼球运动受限。虽然眼球突出不被认为是CPEO的常见特征,但本研究聚焦于CPEO患者中眼球突出的发生率。
回顾性观察病例系列
我们回顾了在2010年1月至2018年12月期间被诊断为CPEO的患者的临床病历。CPEO的诊断基于从斜视手术中获取的唾液、颊黏膜或眼外肌标本中检测到线粒体DNA(mtDNA)缺失。使用水平MRI/CT图像或Hertel眼球突出计来确定眼球突出。
共确定了7例患者(4例男性)。诊断时的平均年龄为32.6岁(范围13 - 53岁)。5例患者的颊黏膜DNA中检测到mtDNA缺失突变,2例患者的唾液和眼外肌DNA中检测到该突变。6例患者进行了MRI/CT检查,其中4例显示眼球突出(病例1 - 4),病例5根据Hertel眼球突出计读数被确定为眼球突出。4例患者(病例1、2、4和5)的眼球突出为双侧性,1例患者(病例3)为单侧性。2例患者主要关注眼球突出;然而,在其他患者中这一情况在临床上并不显著。
虽然患者或临床医生可能未认识到眼球突出,但它可能是CPEO的常见特征之一。应开展一项大型多民族研究。